Research review
Does lycopene help with inflammation? What the research does and doesn't show
Pooled trial evidence on lycopene and general inflammation markers is mixed — one meta-analysis found a reduction in CRP and IL-6, the largest found none — and no human trial has tested lycopene against prostate inflammation or gout specifically; the prostatitis evidence is limited to a rat study.
Trial evidence on lycopene and general inflammation markers is mixed: one meta-analysis found a reduction in two inflammatory markers, the largest and most recent found none. For prostate inflammation specifically, the only direct evidence is a rat study; no human trial exists. Nothing tested lycopene against gout at all.
What the evidence doesn't support
It doesn't support lycopene as a dependable way to lower general inflammation markers: the largest pooled analysis, 34 randomized trials, found no significant effect on CRP, IL-6 or TNF-alpha, even though a smaller, earlier meta-analysis and one individual trial did find reductions in some of those same markers. It doesn't support lycopene as a treatment for chronic prostatitis or prostate inflammation in people — the only research testing that specific question used rats, not humans, and no clinical trial has followed up on it. And on gout specifically, there's nothing to report either way: no study was found testing lycopene against gout risk or uric acid levels, so this doesn't confirm or rule out an effect.
What the trials found
A 2023 meta-analysis of 34 randomized trials tested lycopene and tomato products against a battery of cardiovascular and inflammatory markers, including CRP, IL-6 and TNF-alpha. None of those markers changed significantly across the pooled trials; the only significant change anywhere in that analysis was in a marker of oxidative stress, not inflammation.
A 2017 meta-analysis of 21 trials found the opposite for one marker: tomato-product supplementation was linked to a significant reduction in IL-6, alongside an LDL cholesterol reduction, though most other outcomes tracked showed no significant change. Separately, a 2024 randomized trial gave 80 adults with metabolic syndrome either 20 mg/day of encapsulated lycopene or placebo for 8 weeks and found a significant reduction in CRP, a commonly used inflammation marker, in the lycopene group.
For prostate inflammation specifically, the only study found used rats. Researchers induced a chronic prostatitis/pelvic pain model and gave lycopene daily for 4 weeks; treated rats had less prostate tissue damage and smaller amounts of several inflammatory markers than untreated model rats. No human trial has tested lycopene against chronic prostatitis, prostatitis symptoms or prostate inflammation.
No study was found linking lycopene to gout, uric acid levels, or gout flares in either direction.
Questions people ask
Does lycopene help with prostate inflammation?
The only evidence is a single rat study, where lycopene reduced inflammatory markers in a chemically induced prostatitis model. That hasn't been tested in a person, so it doesn't support using lycopene for prostate inflammation in humans.
Can lycopene cause gout?
No research was found testing lycopene against gout or uric acid at all, so there's no evidence it causes gout — and no evidence it prevents it either. This is an unanswered question, not a settled one.
When to talk to a doctor
Anyone with symptoms of prostatitis, gout, or a broader inflammatory condition should see a doctor for diagnosis and treatment rather than relying on a supplement. Lycopene is not a treatment for prostate inflammation, gout, or inflammation generally, and the evidence above doesn't support using it that way.
Related reading: lycopene: what the research does and doesn't show, lycopene and cholesterol, reviewed, and what is lycopene.
Sources
- The Effects of Lycopene and Tomato Consumption on Cardiovascular Risk Factors in Adults: A Grade Assessment Systematic Review and Meta-analysis A meta-analysis of 34 randomized trials found lycopene and tomato products had no significant effect on blood pressure, cholesterol, blood sugar, inflammation or body weight; the only significant change was in an oxidative-stress marker.
- Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis A meta-analysis of 21 randomized trials found tomato product supplementation significantly reduced LDL cholesterol and an inflammatory marker, but no other cardiovascular measure changed significantly.
- The Effects of Lycopene on Modulating Oxidative Stress and Liver Enzymes Levels in Metabolic Syndrome Patients: A Randomised Clinical Trial A randomized trial of 80 adults with metabolic syndrome found 20 mg/day of encapsulated lycopene for 8 weeks reduced CRP and an oxidative-stress marker versus placebo, with no change in liver enzymes.
- Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs, and Nrf2 signaling pathways in rats A rat study found lycopene reduced prostate inflammation markers and tissue damage in a chemically induced chronic prostatitis model — an animal result, with no human trial testing whether lycopene affects chronic prostatitis or prostate inflammation in people.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.